| http://www.w3.org/ns/prov#value | - In 2006, extensively drug resistant TB (XDR-TB) emerged with resistance to first and second line drugs which is a serious emerging threat to global health. (1) Extensively drug resistant (XDR) TB (MDR TB with additional resistance to at least a fluoroquinolone and one of the injectables i.e. kanamycin, amikacin or capreomycin) has been reported in 77 countries across the globe by October 2011. (2)
|
